Trials / Recruiting
RecruitingNCT07154823
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 550 (estimated)
- Sponsor
- Tempus AI · Industry
- Sex
- All
- Age
- 0 Years
- Healthy volunteers
- Not accepted
Summary
The TEMPUS AQUARIUS Study is a non-interventional, longitudinal observational study focused on hematological malignancies. It will collect rich molecular (multi-omic) and clinical data from patient cohorts through serial blood draws and the acquisition of leftover tissue and/or bone marrow aspirates during their routine therapy and disease monitoring. The primary goal is to understand the association between biomarkers and real-world clinical outcomes in these patient populations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | None - Observational Study | There are no interventions in this observational study. |
Timeline
- Start date
- 2026-01-27
- Primary completion
- 2034-11-01
- Completion
- 2035-11-01
- First posted
- 2025-09-04
- Last updated
- 2026-03-03
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT07154823. Inclusion in this directory is not an endorsement.